Latest News, Grants & Research Reports
Read our latest news, blog posts and research updates right here
Developing personalised treatment for ALK-positive neuroblastoma
Thanks to funding from Neuroblastoma UK, post-doctoral research associate Dr Perla Pucci was recruited to join a neuroblastoma research team at the University of Cambridge.
The team, led by Dr Suzanne Turner, are looking to develop more personalised treatment for children with ALK-positive neuroblastoma. Perla tells us more about how the project has progressed.
Developing personalised treatment for children with neuroblastoma
In 2019, we awarded £236,141 to Dr Suzanne Turner at the University of Cambridge, as part our 2019 research grant round.
Here we meet Dr Turner and find out more about her three year research project aimed at improving the effectiveness of ALK inhibitors for children with neuroblastoma.
Using 3D printing to study neuroblastoma
We are providing funding of over £116,000 to Dr Olga Piskareva and her team at the Royal College of Surgeons in Ireland (RCSI).
In this project, Dr Piskareva aims to use 3D printing technology to engineer a novel experimental model and study the biology, and subsequent treatment of, neuroblastoma. “Thanks to funding from Neuroblastoma UK and its dedicated supporters...we hope to develop more effective treatments for children with neuroblastoma, with more tolerable side-effects.”
Improving survival for children with rare cancer
Earlier this year, Neuroblastoma UK joined forces with childhood cancer charities Niamh’s Next Step and The Bradley Lowery Foundation to fund more vital research into neuroblastoma.
“...If this project is successful, it would hopefully lead to the subsequent development of a clinical antibody, for trial in children with neuroblastoma…”